Efficacy News and Research

RSS
PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

pSivida presents data of ILUVIEN Phase 3 trial in Diabetic Macular Edema at ARVO 2011

pSivida presents data of ILUVIEN Phase 3 trial in Diabetic Macular Edema at ARVO 2011

CTI to re-submit pixantrone NDA to FDA's Office of New Drugs for re-review

CTI to re-submit pixantrone NDA to FDA's Office of New Drugs for re-review

Desirudin more effective for VTE prevention in patients with renal impairment

Desirudin more effective for VTE prevention in patients with renal impairment

Asthma research on its way to help sufferers

Asthma research on its way to help sufferers

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Affinium announces AFN-1252 Phase I study results in staphylococcal infections

Affinium announces AFN-1252 Phase I study results in staphylococcal infections

Statins can help reduce lung damage in severe abdominal sepsis

Statins can help reduce lung damage in severe abdominal sepsis

Merck's Phase III study shows efficacy results of tafluprost to treat ocular hypertension

Merck's Phase III study shows efficacy results of tafluprost to treat ocular hypertension

Positive Ellex 2RT data demonstrates efficacy in treatment of early Age-Related Macular Degeneration

Positive Ellex 2RT data demonstrates efficacy in treatment of early Age-Related Macular Degeneration

Caliper first quarter revenue increases 25% to $35.8 million

Caliper first quarter revenue increases 25% to $35.8 million

Many herbal medicines banned under EU directives

Many herbal medicines banned under EU directives

PURE named winner of CSN 2011 National Child Safety Award

PURE named winner of CSN 2011 National Child Safety Award

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Avastin, Lucentis are equally effective for age-related macular degeneration treatment

Avastin, Lucentis are equally effective for age-related macular degeneration treatment

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Portuguese researcher to earn Bill & Melinda Gates Foundation award for new HIV therapy

Portuguese researcher to earn Bill & Melinda Gates Foundation award for new HIV therapy

Researchers report Avastin is effective as Lucentis for AMD treatment

Researchers report Avastin is effective as Lucentis for AMD treatment

Top-line results from Pfizer's tofacitinib Phase 3 studies in RA

Top-line results from Pfizer's tofacitinib Phase 3 studies in RA

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.